These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 35664182)

  • 21. Why do sports goods manufacturers choose different corporate social responsibility engagements?
    Guo Y; Kang D; Huang C; Chen Y
    PLoS One; 2023; 18(12):e0295682. PubMed ID: 38128059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does CSR Activity Amount to Socially Responsible Management?
    Foster MJ
    Philos Manag; 2021; 20(4):391-410. PubMed ID: 33526999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.
    Droppert H; Bennett S
    Global Health; 2015 Apr; 11():15. PubMed ID: 25886175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corporate social responsibility initiatives and their role in firms' reputation and green economic recovery through organizational trust.
    Zheng SY; Chen R; Liu H; Li J; Fahad S; Li B
    Environ Sci Pollut Res Int; 2023 Sep; 30(45):101817-101828. PubMed ID: 37659017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Female CEO succession and corporate social disclosure in China: unveiling the significance of ownership status and firm performance.
    Shaheen R; Luo Q; Bala H
    Environ Sci Pollut Res Int; 2023 Feb; 30(6):14223-14239. PubMed ID: 36149559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Chief Executive Officer and Board Prior Corporate Social Responsibility Experiences on Their Focal Firm's Corporate Social Responsibility: The Moderating Effect of Chief Executive Officer Overconfidence.
    Al-Shammari M; Al-Shammari H; Banerjee SN; Doty DH
    Front Psychol; 2022; 13():891331. PubMed ID: 35941949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the Effect of Board Gender Diversity on CSR Reporting Through Moderating Role of Political Connections in Chinese Listed Firms.
    Shaheen R; Yang H; Bhutto MY; Bala H; Khan FN
    Front Psychol; 2021; 12():796470. PubMed ID: 35035372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nexus of the CSR disclosures and corporate financial performance: evidence from Asian countries climate policy uncertainty.
    Waris M; Din BH
    Environ Sci Pollut Res Int; 2024 Jan; 31(2):1995-2008. PubMed ID: 38049691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Employee wellbeing and cost reduction drivers of corporate social responsibility: Evidence from Congolese mining sector.
    Sun H; Bahizire GM
    Front Psychol; 2022; 13():850283. PubMed ID: 36814886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Corporate Social Responsibility Boosts Corporate Financial and Non-financial Performance: The Moderating Role of Ethical Leadership.
    Bouichou SI; Wang L; Zulfiqar S
    Front Psychol; 2022; 13():871334. PubMed ID: 35693531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CEO birth order and corporate social responsibility behaviors: The moderating effect of female sibling and age gap.
    Zheng M; Ren G; Wu S; Jiang Z
    Front Psychol; 2022; 13():1003704. PubMed ID: 36405214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity of returnee executives' foreign experience and corporate social responsibility performance.
    Wu Y; Zhang W; Li H
    PLoS One; 2024; 19(4):e0300262. PubMed ID: 38557680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are R&D-Intensive firms also corporate social responsibility specialists? A multicountry study.
    Fu L; Boehe D; Orlitzky M
    Res Policy; 2020 Oct; 49(8):104082. PubMed ID: 32834183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of corporate social responsibility on the financial and non-financial performance of the banking sector: A moderated and mediated mechanism.
    Sindhu MI; Windijarto ; Wong WK; Maswadi L
    Heliyon; 2024 May; 10(9):e30557. PubMed ID: 38726119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
    Zhong M; Zhao W; Shahab Y
    Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship Between CEO Duality and Business Firms' Performance: The Moderating Role of Firm Size and Corporate Social Responsibility.
    Mubeen R; Han D; Abbas J; Álvarez-Otero S; Sial MS
    Front Psychol; 2021; 12():669715. PubMed ID: 35035363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into corporate sustainability, environmental management and corporate financial performance in European Union: an application of VAR and Granger causality approach.
    Ivascu L; Domil A; Sarfraz M; Bogdan O; Burca V; Pavel C
    Environ Sci Pollut Res Int; 2022 Nov; 29(55):82827-82843. PubMed ID: 35754081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring the association of environmental, corporate, financial, and social CSR: evidence from fuzzy TOPSIS nexus in emerging economies.
    Kamran HW; Pantamee AA; Patwary AK; Ghauri TA; Long PD; Nga DQ
    Environ Sci Pollut Res Int; 2021 Mar; 28(9):10749-10762. PubMed ID: 33099740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can corporate social responsibility protect firm value during the COVID-19 pandemic?
    Qiu SC; Jiang J; Liu X; Chen MH; Yuan X
    Int J Hosp Manag; 2021 Feb; 93():102759. PubMed ID: 36919172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of China's Vaccine Incidents on the Operational Efficiency of Biopharmaceutical Companies.
    Chai KC; Tao R; Chang KC; Yang Y
    Front Public Health; 2020; 8():93. PubMed ID: 32322567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.